4th Quarter - Report
CROSSROADS STRATEGIES, LLC for GENENTECH, INC.
Client
Income
$50,000
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
Monitored H.J.RES.59, Continuing Appropriations Resolution, 2014.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANNE BRADY | — |
| JOHN GREEN | — |
| STEWART HALL | — |
| MATHEW LAPINSKI | — |
| HUNTER MOORHEAD | — |
| STEVE TILTON | — |
| TODD MATTHEW WEISS | — |
| MATT WISE | — |
Medicare/Medicaid MMM
Issues related to H.R.2810, Medicare Patient Access and Quality Improvement Act of 2013. Medicare reimbursement issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANNE BRADY | — |
| JOHN GREEN | — |
| STEWART HALL | — |
| MATHEW LAPINSKI | — |
| HUNTER MOORHEAD | — |
| STEVE TILTON | — |
| TODD MATTHEW WEISS | — |
| MATT WISE | — |
Health Issues HCR
S.959, Pharmaceutical Compounding Quality and Accountability Act; H.R.1416, Cancer Patient Protection Act of 2013; S.957, Drug Supply Chain Security Act; H.R.1919, Safeguarding America's Pharmaceuticals Act of 2013; pharma supply chain issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANNE BRADY | — |
| JOHN GREEN | — |
| STEWART HALL | — |
| MATHEW LAPINSKI | — |
| HUNTER MOORHEAD | — |
| STEVE TILTON | — |
| TODD MATTHEW WEISS | — |
| MATT WISE | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.